Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, BRCA gene mutations in cancer, and Colorectal Cancer Treatments and Studies.
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
ANKRD26-related thrombocytopenia: Hematologic malignancy characteristics, clinical outcomes, and precursor states
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Microsatellite Instability–High Endometrial Cancers with <i>MLH1</i> Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants
Body mass index and molecular subtypes of colorectal cancer
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers
Inherited TP53 Variants and Risk of Prostate Cancer
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes
A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study
Salicylic acid and risk of colorectal cancer: a two sample Mendelian randomization study
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening
Protein-altering germline mutations implicate novel genes related to lung cancer development